Drug Class
RANKL inhibitor
Type
brand
Active Ingredient
denosumab
📋Overview
Xgeva is a medication that targets a protein involved in bone breakdown. It is commonly used in conditions where bone loss or bone complications are a concern, such as certain cancers that have spread to the bones. By inhibiting this protein, Xgeva helps reduce the risk of bone-related events in affected individuals. It is often associated with oncology and bone health management.
📚References
Information from MedlinePlus.gov (NIH).
Found an Error?
Help us keep this information accurate. If you notice any incorrect details, please submit a correction request.
Find Discounts for Xgeva
Hospitals.net Disclosure
Hospitals.net is an independent healthcare information platform and does not provide, administer, or guarantee prescription discounts, pricing, coupons, or pharmacy participation. All discount pricing and availability shown above are provided by RxGo and its partners and are subject to change without notice.
Hospitals.net may receive a commission or referral fee if you choose to use this prescription discount service. This does not affect the price you pay at the pharmacy. Hospitals.net is not responsible for pricing accuracy, pharmacy participation, or the fulfillment of any discount offers.
